New Anti-Obesity Medications Should Be Consider...

By HEOR Staff Writer

August 6, 2024

Introduction Federal policymakers are evaluating a new class of drugs for managing and preventing type 2 diabetes symptoms. These medications, known as glucagon-like peptide-1 (GLP-1) receptor agonists, have shown unexpected success in w...
Impact of Air Pollution on Birth Outcomes: Evidence from Northern Ireland
Enhancing COPD Management: Insights from Recent Meta-Analysis on Utility Values
Adolescent Scoliosis in Gansu Province: A Comprehensive Study
How Socioeconomic Status Influences Lung Cancer Screening and Prognosis Over ...
Revealing the Hidden Impact: Family Spillover Effects
Modernising AI Medical Devices Regulation: FDA’s Firm-Based Approach
Abu Dhabi Strategic Healthcare Partnerships: Global Collaborations
Genome-Wide Sequencing in Diagnosing Rare Diseases: Clinical and Economic Imp...
Antenatal HCV Screening in Egypt: Paving the Path to Elimination
The Economic Burden of Liver Transplantation for Hepatitis B in Italy
Impact of Brain Cancer Care Coordinators on Healthcare Utilisation
Economic Burden of Juvenile Idiopathic Arthritis in Spain